UCLA Calabasas Specialty Care — Calabasas, California

UCLA Calabasas Specialty Care is a clinical research site located in Calabasas, California, United States 91302.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

UCLA Calabasas Specialty Care has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Urothelial Carcinoma.

Sponsors: Seagen, a wholly owned subsidiary of Pfizer.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for UCLA Calabasas Specialty Care?

UCLA Calabasas Specialty Care has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has UCLA Calabasas Specialty Care conducted?

UCLA Calabasas Specialty Care has 1 clinical trials on record, with 1 currently active. Their work covers Urothelial Carcinoma.

Is UCLA Calabasas Specialty Care accredited by Crixeo Health?

UCLA Calabasas Specialty Care has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about UCLA Calabasas Specialty Care?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.